Semaglutide is a glucagon-like peptide-1 (GLP-1 receptor agonist) that belongs to a class of drugs called incretin mimetics
Participants who lost 15 percent or more of their body weight saw larger reductions in systolic blood pressure (around 10 mmHg versus 4 mmHg in those losing less) and diastolic pressure (around 4 mmHg versus 1 mmHg), with greater falls in C-reactive protein and non-HDL cholesterol as well (Patient Care Online, 2026)
Made in a plant that manufactures milk, egg, gluten, soy, crustaceans, sulphur dioxide and nuts containing foods
Patients also often report quicker results with injections compared to weeks or months using oral supplements
As consumers, choosing organically grown black seed oil and other organic face oils is a step towards supporting sustainable agricultural practices
Outcomes from GLP-1 therapy are best when paired with ongoing dietitian counseling and lifestyle support (Gigliotti et al., 2025)